Division Of Firms, Business And Skilled Licensing
While the UK government has embraced Innova’s lateral circulate tests, regulators within the company’s domestic market, the US, haven’t. The US Food and Drug Administration recalled Innova’s tests last year, citing considerations about their reliability. Innova’s chief executive, Daniel Elliott, has stated that Disruptive Nanotechnology co-owner Thonger, who based the corporate in 2016, “worked tirelessly” to assist Innova win the first of its contracts. Accounts filed at Companies House last month present that the firm’s internet property soared to £20.5m in the course of the 12 months to 31 December 2020, together with the first 9 months of the coronavirus…